ロード中...
The perfect personalized cancer therapy: cancer vaccines against neoantigens
In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastatic disease in several solid and liquid tumor types. It is now clear that ICI acts by unmaski...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5910567/ https://ncbi.nlm.nih.gov/pubmed/29678194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0751-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|